The 17D-204 and 17DD yellow fever vaccines: an overview of major similarities and subtle differences
- 1 January 2018
- journal article
- review article
- Published by Informa UK Limited in Expert Review of Vaccines
- Vol. 17 (1), 79-90
- https://doi.org/10.1080/14760584.2018.1406800
Abstract
Introduction: The yellow fever vaccine is a live attenuated virus vaccine that is considered one of the most efficient vaccines produced to date. The original 17D strain generated the substrains 17D-204 and 17DD, which are used for the current production of vaccines against yellow fever. The 17D-204 and 17DD substrains present subtle differences in their nucleotide compositions, which can potentially lead to variations in immunogenicity and reactogenicity. We will address the main changes in the immune responses induced by the 17D-204 and 17DD yellow fever vaccines and report similarities and differences between these vaccines in cellular and humoral immunity. This is a relevant issue in view of the re-emergence of yellow fever in Uganda in 2016 and in Brazil in the beginning of 2017. Areas covered: This article will be divided into 8 sections that will analyze the innate immune response, adaptive immune response, humoral response, production of cytokines, immunity in children, immunity in the elderly, gene expression and adverse reactions. Expert commentary: The 17D-204 and 17DD yellow fever vaccines present similar immunogenicity, with strong activation of the cellular and humoral immune responses. Additionally, both vaccines have similar adverse effects, which are mostly mild and thus are considered safe.Keywords
This publication has 73 references indexed in Scilit:
- 17DD and 17D-213/77 Yellow Fever Substrains Trigger a Balanced Cytokine Profile in Primary Vaccinated ChildrenPLOS ONE, 2012
- Elderly Subjects Have a Delayed Antibody Response and Prolonged Viraemia following Yellow Fever Vaccination: A Prospective Controlled Cohort StudyPLOS ONE, 2011
- CXCR3 in T cell functionExperimental Cell Research, 2011
- CD8+ gamma-delta TCR+ and CD4+ T cells produce IFN-γ at 5–7 days after yellow fever vaccination in Indian rhesus macaques, before the induction of classical antigen-specific T cell responsesVaccine, 2010
- Clinical and Immunological Insights on Severe, Adverse Neurotropic and Viscerotropic Disease following 17D Yellow Fever VaccinationClinical and Vaccine Immunology, 2010
- Yellow fever vaccine induces integrated multilineage and polyfunctional immune responsesThe Journal of Experimental Medicine, 2008
- Structural Insights into the Mechanisms of Antibody-Mediated Neutralization of Flavivirus Infection: Implications for Vaccine DevelopmentCell Host & Microbe, 2008
- Yellow fever and Max Theiler: the only Nobel Prize for a virus vaccineThe Journal of Experimental Medicine, 2007
- Distinct gene expression profiles in peripheral blood mononuclear cells from patients infected with vaccinia virus, yellow fever 17D virus, or upper respiratory infectionsVaccine, 2007
- Activation/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: is this the key to prevent severe adverse reactions following immunization?Clinical and Experimental Immunology, 2007